Willis Johnson & Associates’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,302
Closed -$227K 102
2021
Q4
$227K Hold
1,302
0.03% 89
2021
Q3
$216K Hold
1,302
0.03% 88
2021
Q2
$234K Buy
1,302
+56
+4% +$10.2K 0.03% 82
2021
Q1
$240K Buy
+1,246
New +$240K 0.04% 78

Other funds holding CLX

Willis Johnson & Associates's CLX Position: Q1 2022 in Review

Willis Johnson & Associates sold out of Clorox (CLX) in Q1 2022, closing a stake of 1,302 shares — an estimated $227K sold.

Willis Johnson & Associates first reported a position in CLX in Q1 2021 and held it in 4 quarters. The position peaked at $240K in Q1 2021. 1,095 funds tracked by Wall St. Rank hold CLX as of Q1 2022.

  • Willis Johnson & Associates reported no remaining Clorox position as of Q1 2022 after selling out during the quarter.
  • Willis Johnson & Associates sold 1,302 Clorox shares in Q1 2022, an estimated $227K.
  • Willis Johnson & Associates first reported a position in Clorox in Q1 2021 and held it in 4 quarters.
  • Willis Johnson & Associates's Clorox position peaked at $240K in Q1 2021.
  • 1,095 funds tracked by Wall St. Rank held Clorox as of Q1 2022.

Based on Willis Johnson & Associates's 13F filing for Q1 2022, filed 10 May 2022.